Tags : GI Innovation

Pharma

Yuhan Collaborates with GI Innovation for its Allergy Treatment Worth

Shots: GI Innovations to receive $17M upfront, $1.2B as development & commercialization milestones along with royalties on sales of therapy Yuhan to get global rights (Ex-Japan) to develop and commercialize GI-301 while collaborates with GI Innovations for the development of therapy As per collaboration, the companies will develop allergy treatment across all four major allergic […]Read More